172 related articles for article (PubMed ID: 36726200)
1. USP53 Regulates Bone Homeostasis by Controlling Rankl Expression in Osteoblasts and Bone Marrow Adipocytes.
Hariri H; Kose O; Bezdjian A; Daniel SJ; St-Arnaud R
J Bone Miner Res; 2023 Apr; 38(4):578-596. PubMed ID: 36726200
[TBL] [Abstract][Full Text] [Related]
2. Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow.
Mousa A; Cui C; Song A; Myneni VD; Sun H; Li JJ; Murshed M; Melino G; Kaartinen MT
Cell Death Differ; 2017 May; 24(5):844-854. PubMed ID: 28387755
[TBL] [Abstract][Full Text] [Related]
3. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin specific peptidase Usp53 regulates osteoblast versus adipocyte lineage commitment.
Hariri H; Addison WN; St-Arnaud R
Sci Rep; 2021 Apr; 11(1):8418. PubMed ID: 33875709
[TBL] [Abstract][Full Text] [Related]
5. IL-1 plays an important role in the bone metabolism under physiological conditions.
Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
[TBL] [Abstract][Full Text] [Related]
6. Overloaded Orthopedic Force Induces Condylar Subchondral Bone Absorption by Stimulating Rat Mesenchymal Stem Cells Differentiating into Osteoclasts via mTOR-Regulated
Tian Y; Chen J; Yan X; Ren D; Liu M; Zhang Q; Zhang Q; Yuan X
Stem Cells Dev; 2021 Jan; 30(1):29-38. PubMed ID: 33176606
[TBL] [Abstract][Full Text] [Related]
7. Osteoblast-Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone.
Cappariello A; Loftus A; Muraca M; Maurizi A; Rucci N; Teti A
J Bone Miner Res; 2018 Mar; 33(3):517-533. PubMed ID: 29091316
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 as a novel regulator of osteoblast-osteoclast interaction and bone homeostasis.
Simon D; Derer A; Andes FT; Lezuo P; Bozec A; Schett G; Herrmann M; Harre U
Bone; 2017 Dec; 105():35-41. PubMed ID: 28822790
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-29a represses osteoclast formation and protects against osteoporosis by regulating PCAF-mediated RANKL and CXCL12.
Lian WS; Ko JY; Chen YS; Ke HJ; Hsieh CK; Kuo CW; Wang SY; Huang BW; Tseng JG; Wang FS
Cell Death Dis; 2019 Sep; 10(10):705. PubMed ID: 31543513
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of osteoblastic Arl6ip5 impaired osteoblast differentiation and enhanced osteoclastogenesis via disturbance of ER calcium homeostasis and induction of ER stress-mediated apoptosis.
Wu Y; Yang M; Fan J; Peng Y; Deng L; Ding Y; Yang R; Zhou J; Miao D; Fu Q
Cell Death Dis; 2014 Oct; 5(10):e1464. PubMed ID: 25321471
[TBL] [Abstract][Full Text] [Related]
11. Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development.
Mukherjee A; Rotwein P
Mol Cell Biol; 2012 Jan; 32(2):490-500. PubMed ID: 22064480
[TBL] [Abstract][Full Text] [Related]
12. IL-3 Differentially Regulates Membrane and Soluble RANKL in Osteoblasts through Metalloproteases and the JAK2/STAT5 Pathway and Improves the RANKL/OPG Ratio in Adult Mice.
Singh K; Piprode V; Mhaske ST; Barhanpurkar-Naik A; Wani MR
J Immunol; 2018 Jan; 200(2):595-606. PubMed ID: 29203513
[TBL] [Abstract][Full Text] [Related]
13. SMURF2 regulates bone homeostasis by disrupting SMAD3 interaction with vitamin D receptor in osteoblasts.
Xu Z; Greenblatt MB; Yan G; Feng H; Sun J; Lotinun S; Brady N; Baron R; Glimcher LH; Zou W
Nat Commun; 2017 Feb; 8():14570. PubMed ID: 28216630
[TBL] [Abstract][Full Text] [Related]
14. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation.
Zhu Q; Zhou X; Zhu M; Wang Q; Goltzman D; Karaplis A; Miao D
J Bone Miner Res; 2013 Sep; 28(9):1898-911. PubMed ID: 23716486
[TBL] [Abstract][Full Text] [Related]
15. Mst2 Controls Bone Homeostasis by Regulating Osteoclast and Osteoblast Differentiation.
Lee J; Youn BU; Kim K; Kim JH; Lee DH; Seong S; Kim I; Han SH; Che X; Choi JY; Park YW; Kook H; Kim KK; Lim DS; Kim N
J Bone Miner Res; 2015 Sep; 30(9):1597-607. PubMed ID: 25761670
[TBL] [Abstract][Full Text] [Related]
16. IDH2 deficiency increases bone mass with reduced osteoclastogenesis by limiting RANKL expression in osteoblasts.
Lee SH; Lee SH; Lee JH; Park JW; Kim JE
Bone; 2019 Dec; 129():115056. PubMed ID: 31479775
[TBL] [Abstract][Full Text] [Related]
17. Histone demethylase KDM7A regulates bone homeostasis through balancing osteoblast and osteoclast differentiation.
Shan L; Yang X; Liao X; Yang Z; Zhou J; Li X; Wang B
Cell Death Dis; 2024 Feb; 15(2):136. PubMed ID: 38346941
[TBL] [Abstract][Full Text] [Related]
18. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
[TBL] [Abstract][Full Text] [Related]
19. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
